Skip to content

Melatonin Versus Hydroxizin for Pre Operative Anxiety in Elderly Patients With Hip Fracture

Melatonin Versus Hydroxizin for Pre Operative Anxiety in Elderly Patients With Hip Fracture

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05224167
Enrollment
50
Registered
2022-02-04
Start date
2022-03-01
Completion date
2022-07-30
Last updated
2022-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preoperative Anxiety

Keywords

Melatonin, Hydroxizin, Hip fracture

Brief summary

prospective randomized trial including adukt patients scheduled for hip fracture surgery, Randomization into 2 groups: Group A: Hydroxizin peroperatively Group B: Melatonin pre operatively

Detailed description

prospective randomized trial including adukt patients scheduled for hip fracture surgery, Randomization into 2 groups: Group A: Hydroxizin peroperatively Group B: Melatonin pre operatively Non inclusion criteria: patients with severe cognitive impairement Primary outcome pre operative anxiety assessed with Amsterdam preoperative anxiety and information scale

Interventions

DRUGMelatonin 5 MG Sublingual Tablet

Melatonin 5 mg 12 hours and 2 hours prior to surgery

Hydroxyzine 1mg/kg 12 hours and 2 hours prior to surgery

Sponsors

Mongi Slim Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* All adult patients scheduled for hip fracture surgery

Exclusion criteria

* Patients with contraindications for hydroxizine or Melatonin Patients with severe cognitive impairement

Design outcomes

Primary

MeasureTime frameDescription
preoperative anxiety1 hour before surgerypreoperative anxiety scale

Contacts

Primary ContactMhamed Sami Mebazaa, Prof
msmebazaa@gmail.com0021622252589
Backup ContactAsma Ben Souissi, Assoc Prof
bsouissiasma@gmail.com0021698336883

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026